| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005053-197811000-00002 |
| P698 | PubMed publication ID | 722296 |
| P2093 | author name string | G. Winokur | |
| M. Lowry | |||
| D. Behar | |||
| C. Vanvalkenburg | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 764-768 | |
| P577 | publication date | 1978-11-01 | |
| P1433 | published in | Journal of Nervous and Mental Disease | Q598644 |
| P1476 | title | Is a familial definition of depression both feasible and valid? | |
| P478 | volume | 166 |
| Q36936474 | Acute phase cognitive therapy for recurrent major depressive disorder: who drops out and how much do patient skills influence response? |
| Q71438281 | Bipolar manic-depressive psychoses: results of a genetic investigation |
| Q38165112 | Cognitive factors and classification issues in adolescent depression |
| Q48870406 | Dysregulation of hypothalamic-pituitary-adrenal axis function in depressed alcoholic patients |
| Q51917624 | Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. |
| Q72518511 | Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study |
| Q39540053 | Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic-pituitary-adrenal axis activity |
| Q49096077 | Low levels of somatostatin in human CSF mark depressive episodes |
| Q52092504 | Plasma GABA levels in psychiatric illness |
| Q34195690 | Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial |
| Q43934068 | Prognostic validity of the familial subtypes of depression |
| Q52101623 | The pain-prone disorder: A clinical and psychological profile |
| Q33860963 | Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial |
Search more.